Research Funded

Grant Title Principle Investigator & Affiliation
HHV-6 Specific CD8+ T cell Responses Sudhir Gupta, MD, PhD, MACP University of California Irvine, California USA
Development of a Variant-specific, Calibrated Real-time PCR Assay for the Absolute Quantification of HHV-6A and B Nucleic Acids in Clinical Samples

Mauro S. Malnati, MD
San Raffaele Scientific Institute
Milan, Italy  USA

The Human Herpesvirus 6A U45 Gene Product: Role in Immune Dysfunction

Marshall Williams, PhD
Ohio State University, USA

Variant Specific PCR ELISA

Yi-Wei Tang, MD, PhD
Vanderbilt University, USA

Evaluation of the Antiviral Activity of Glycyrrhizic Acid on Herpesvirus 6

Francesca Curreli, PhD
NYU School of Medicine, USA

Determination of the chromosomal integration of the HHv-6 virus in highly seropositive Chronic Fatigue Syndrome patients

Daniel L. Peterson, MD
Sierra Internal Medicine, Nevada, USA

The role of chronic immune stimulation by active  herpesvirus 6 (HHV6) infection/coinfections in immune dysfunction and development of lymphoma

Daniel L. Peterson, MD
Sierra Internal Medicine, Nevada, USA

Investigation of inhibitory effects of the multipotent drug Artesunate against HHV-6

Manfred Marschall, PhD
Universität Erlangen-Nürnberg, Germany

Creation of a humanized CD46 mouse model for HHV6 infection

Claude P. Genain, MD
California Pacific Medical Center Research Institute, San Francisco USA

Study of HHV-6 & EBV in patients with CNS Dysfunction and long-standing fatigue

Jose Montoya, MD
Stanford University, USA

Use of recombinant viral proteins for the identification of active HHV-6 infection by serological assays

Louis Flamand, PhD,
Universite Laval, Quebec, Canada, USA

Cloning the HHV-6 A and B genome for the identification of genes responsible for pathogenicity Peter Medveczky, MD
University of South Florida, College of Medicine, USA




 


Copyright © 2004 HHV-6 Foundation     site design by hansen design house